Tag: Nigel Layton
Reform of NHS levy ‘harms UK competitiveness’
Boards in the pharmaceutical and life sciences sector face increasingly difficult decisions, according to a recent Board Agenda podcast.
- Governance
- Strategy
- Risk
- Ethics